Skip to content
777 Sourcing.

Capability

cell biology

Suppliers
4
States & provinces
4
Countries
2

4 cell biology suppliers across 4 states and provinces in 2 countries. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ALUDA PHARMACEUTICALS INC

UNION CITY, CA

Aluda Pharmaceuticals is a drug discovery company focused on novel targets for complex diseases, particularly immune and fibrotic diseases. It designs new drug molecules using tools including CRISPR, proteomic array analysis, genetics, molecular medicine, cell biology, big data, and chemical design, and pioneered proprietary concepts in phenotypic screening. Its lead program is a first-in-class anti-vimentin program for fibrosis.

big datachemical designCRISPRdrug discoverygeneticsmolecular medicinephenotypic screeningproteomic array analysis

ARTHRONOVUS, INC.

SOLON, OH

ArthroNovus was founded in 2025 to pursue development of structural autologous solutions to osteoarthritis. In partnership with experts at University Hospitals and Case Western Reserve University, the company is developing a new therapeutic treatment for focal cartilage defects, aiming to create Anatomically Competent replacement parts sourced from the patient's own cells that preserve and heal native anatomy.

mechanical conditioning of tissuestissue engineering

The Istituto di Ricerca Genetica e Biomedica (IRGB) is a research institute of the Consiglio Nazionale delle Ricerche (CNR), with main offices in Monserrato (Cagliari) and secondary sites in Lanusei, Milan and Sassari. It conducts basic and translational research in genetics and biomedical genomics, including rare genetic diseases, cardiovascular diseases, regenerative medicine and oncology.

bioinformatics/high-performance computingcytogeneticsgenomicsgenotypingliquid biopsymolecular biologymolecular diagnosticsNGS sequencingproteomics

CRESTONE INC

BOULDER, CO

Crestone, Inc. is a clinical stage biopharmaceutical and biotech company in Boulder, Colorado focused on inventing and developing novel mechanism of action small molecule drugs for serious bacterial infections. Its pipeline includes antibacterial agents targeting C. difficile infection, resistant Gram-positive infections such as MRSA and VRE, and nontuberculous mycobacterial (NTM) disease and tuberculosis.

analytical chemistryanalytical (LC-MS, NMR)antimicrobial susceptibility testing according to CLSI guidelinesbiochemistrymedicinal chemistry (synthesis, analog design)microbiological profilingMicrobiologypharmacologyprocess chemistryscale upsynthetic organic chemistry

Related capabilities

Other processes offered by the shops that list cell biology.

Browse all capabilities